285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial. (23rd October 2018)

Record Type:: Journal Article
Title:: 285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial. (23rd October 2018)
Main Title:: 285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial
Authors:: Cortes Castan, J
Martín, M
Pernas Simon, S
Gomez Pardo, P
Lopez-Tarruella, S
Gil Martin, M
Manso, L M
Ciruelos, E M
Perez Fidalgo, J A
Hernando, C
Ademuyiwa, F
Weilbaecher, K
Mayer, I A
Pluard, T
Martinez Garcia, M
Vahdat, L T
Wach, A
Barker, D
Romagnoli, B
Kaufman, P A
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 8
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Issue Display:: Volume 29, Issue 8 (2018)
Year:: 2018
Volume:: 29
Issue:: 8
Issue Sort Value:: 2018-0029-0008-0000
Page Start:
Page End:
Publication Date:: 2018-10-23
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy272.277 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12254.xml